Roger Macklis, M.D.
| Appointed: |
1993 |
| Gender: |
Male |
| Languages: |
English |
Radiation Oncology
Taussig Cancer Institute
Biographical Sketch
Roger M. Macklis, MD, is a Professor of Medicine at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University. He is a Staff member in the Department of Radiation Oncology and chaired the department from 1993 to 2005.
Board-certified in radiation oncology, his clinical interests include breast cancer, pediatric abdominal tumors, biologically targeted radiopharmaceutical therapy, radiosurgery, lymphomas, and various other combinations of automated and computer-assisted technologies. He lectures widely on all of these topics.
Dr. Macklis has been listed in Best Doctors in America, Who’s Who in Medicine and Healthcare, Who’s Who in Science and Engineering, and Who’s Who in America. He has authored more than 100 articles, book chapters, and textbooks. In addition, he is an active member of numerous professional societies including the American Society for Therapeutic Radiology and Oncology and the American Society of Clinical Oncology.
Dr. Macklis’s research interests are focused on new approaches to increasing precision in radiotherapy including biological tumor targeting and automated aspects of focal radiotherapy. He also is involved in research on automated systems for error prevention and quality assurance in medicine.
Dr. Macklis has been the recipient of an Exchange Fellowship to Cambridge, England, given by the American Society of Therapeutic Radiology and Oncology and his leadership committee involvement for this professional society.
Professional Highlights
- Professor of Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University
- Research funding in several areas
- "Who's Who in America" and "Who's Who in the World" (16th ed) and "Best Doctors in America" (national peer-nominated listing), 1998
- President, Society of Chairs of Academic Radiation Oncology Programs, 2002-2005
- National Academy of Sciences Special Task Force on Radiopharmaceutical Sciences and Nuclear Medicine, 2006-2007
Education & Fellowships
| Medical School: | Harvard Medical School, Boston, MA |
|
| Internship: | Brigham & Women's Hospital, Internal Medicine, Boston, MA |
| Residency: | Harvard Medical School, Radiation Oncology, Boston, MA |
| Other Education: | (Undergraduate) Yale University, New Haven, CT |
| Other Education: | (Graduate) Yale University, New Haven, CT |
Additional Training
- BS, MS, Yale College, 1978
Certifications
Specialty Interests
Biologically targeted radiopharmaceutical therapy, Breast Cancer, lymphoma, pediatric abdominal tumors, Ocular Melanoma.
Innovations & Patents
Breast Shield Patent (device for minimization of scatter radiation to the contralateral breast)
Awards & Honors
- American Society of Clinical Oncology (ASCO) Young Investigator Award, 1987
- American Society for Therapeutic Radiology and Oncology (ASTRO) Resident Research Award, 1988
- American Cancer Society Junior Faculty Research Award, 1990
Professional Memberships
- American Society for Therapeutic Radiology and Oncology
- American Society of Clinical Oncology
- Radiation Research Society
- American Cancer Society Advisory Board
Specializes in Diseases and Conditions
Specializes in Services
Industry Relationships
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical education about recent trends. The collaborations are reviewed as part of the Cleveland Clinic’s procedures. The Cleveland Clinic publicly discloses payments to its physicians and scientists for speaking and consulting of $5,000 or more per year, and any equity, royalties, and fiduciary relationships in companies with which they collaborate. In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its doctors’ connections with industry and those of their immediate family members. As of 8/1/2008, Dr. Macklis has reported the financial relationships with the companies listed below. Patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic’s policies on collaborations with industry and innovation management, go to our
Integrity in Innovation page.
Consulting. Dr. Macklis receives fees of $5,000 or more per year as a paid consultant or speaker for the following companies:
Equity. Dr. Macklis owns stock or stock options in the following companies for activities as a founder, inventor, or consultant:
- Navotek Medical, Ltd.
- Within3
( † Disclaimer: This search is powered by PubMed, a service of the U.S.
National Library of Medicine. PubMed is a third-party website with no
affiliation with Cleveland Clinic.)
